Endocrine · Pancreatic Tumors
Islet cell tumors that hijack one hormone and wreck everything downstream. Learn the labs, the C-peptide trap, and the one drug that buys time against all of them.
Read the labs and tap the tumor. Five patients, five tumors. No peeking at the cards first.
Front: key facts. Back: mechanism + boards trap. Tap to flip.
Pancreatic neuroendocrine tumors (PNETs) split on what they secrete. Insulinoma · beta cell. Whipple triad: low glucose + neuroglycopenic symptoms + relief with glucose. C-peptide HIGH (endogenous). Gastrinoma (ZES) · non-beta. Refractory ulcers (especially distal duodenum/jejunum), high serum gastrin + high BAO; secretin test paradoxically raises gastrin. Glucagonoma · alpha cell. 4 Ds: dermatitis (necrolytic migratory erythema), diabetes, DVT, depression. Somatostatinoma · delta. Diabetes + cholelithiasis + steatorrhea (somatostatin shuts off insulin/CCK/secretin). VIPoma · WDHA: watery diarrhea + hypokalemia + achlorhydria. Match the hormone to the syndrome · that's the whole differential.
The three patterns boards love. One look and you should know the tumor.
Glucagon is the catabolic switch. One signal fires from the alpha cell. Three fuels rise at once.
One alpha-cell signal, three catabolic outputs. Type 2 diabetes only nudges the first.
A beta-cell tumor pumps insulin even when blood sugar is empty. The fuel gauge falls. The brain dims.
Symptoms appear when glucose drops; relief comes only when glucose returns. The trap is the C-peptide.
The delta-cell tumor floods the body with the master off-switch. Four downstream systems go quiet.
Somatostatin is the master inhibitor. Four organ outputs shut down at once. The tetrad is unique.
VIP commandeers the gut. Water, potassium, and bicarb pour out of the body. The diarrhea ignores fasting.
Cholera-like watery diarrhea, potassium falling, bicarb gone. The giveaway: a fast does not stop it.
Tumor gastrin storms the parietal cells. Acid floods the stomach, the duodenum, then burns past them.
PPI does not hold. Ulcers march distally. The jejunal lesion is the tell.
Same labs. Two completely different stories. C-peptide picks the side.
C-peptide HIGH · endogenous insulin source · insulinoma or sulfonylurea-induced (sulfa screen). C-peptide LOW · exogenous insulin (factitious or accidental injection). Always check the screen for surreptitious insulin in a healthcare worker / diabetic family member. Insulinoma workup: supervised 72-hour fast · document hypoglycemia with simultaneously inappropriately HIGH insulin, HIGH C-peptide, HIGH proinsulin. Then localize: small (<2cm), often missed on CT · endoscopic ultrasound is the modality of choice. If C-peptide is low · it's NOT insulinoma. Move on.
Now walk it as a case. Each tap reveals the next step.
Tap to unblur. See if you can recall before you look.
Bridge to surgery for every villain on this page. Tap to reveal.
Boards test recognition. Tap to expand.
Five drawn at random per load. No running score shown. You either know it or you learn it.
Two stem patterns to know cold: (1) MEN1 association · any PNET in a patient with hypercalcemia (parathyroid) or pituitary symptoms (acromegaly, prolactinoma, amenorrhea) = MEN1 syndrome · tumors of 3 P's: Parathyroid, Pancreas (gastrinoma most common), Pituitary. (2) ZES + diarrhea-predominant ulcer + MEN1 family history is the classic gastrinoma vignette · localize to the gastrinoma triangle (junction of cystic + CBD, neck/body of pancreas, 2nd/3rd duodenum). Treatment first-line for PNETs: surgical resection if localized + somatostatin analogs (octreotide/lanreotide) to control symptoms. Recognize the syndrome, then recognize MEN1 lurking behind it.